Source:http://linkedlifedata.com/resource/pubmed/id/19166796
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2009-1-26
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1523-6838
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
53
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
183-8
|
| pubmed:meshHeading |
pubmed-meshheading:19166796-Calcium,
pubmed-meshheading:19166796-Humans,
pubmed-meshheading:19166796-Hyperparathyroidism, Secondary,
pubmed-meshheading:19166796-Hyperphosphatemia,
pubmed-meshheading:19166796-Hypocalcemia,
pubmed-meshheading:19166796-Kidney Failure, Chronic,
pubmed-meshheading:19166796-Naphthalenes,
pubmed-meshheading:19166796-Phosphorus
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
|
| pubmed:publicationType |
Editorial,
Comment
|